TAKE Solutions Limited
NSE: TAKE BSE: TAKE
Prev Close
9.18
Open Price
9.36
Volume
12,683
Today Low / High
9.36 / 9.36
52 WK Low / High
6.51 / 23.69
Range
9 - 10
Prev Close
9.11
Open Price
9.29
Volume
10,670
Today Low / High
9.28 / 9.29
52 WK Low / High
6.7 / 23.68
Range
9 - 10
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 9.36 (target range: 9 - 10), reflecting a change of 0.18 (1.96078%). On the BSE, it is listed at 9.28 (target range: 9 - 10), showing a change of 0.17 (1.86608%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
TAKE Solutions Limited Graph
TAKE Solutions Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for TAKE Solutions Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 9.36, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 9.28 | 9.37 | 8.44 - 10.31 |
| 9.47 | 7.57 - 11.36 | ||
| 9.56 | 6.69 - 12.43 | ||
| Bearish Scenario | 9.28 | 9.19 | 8.27 - 10.11 |
| 9.09 | 7.28 - 10.91 | ||
| 9.00 | 6.30 - 11.70 |
Overview of TAKE Solutions Limited
ISIN
INE142I01023
Industry
Biotechnology
Vol.Avg
39,177
Market Cap
1,331,406,000
Last Dividend
0
Official Website
IPO Date
2007-08-27
DCF Diff
8.77
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of TAKE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2019-08-01 | August 01, 19 | 0.4 | 0.4 | 2019-08-02 | 2019-09-06 | 2019-05-16 |
| 2019-02-22 | February 22, 19 | 0.3 | 0.3 | 2019-02-25 | 2019-03-15 | 2019-02-13 |
| 2018-11-09 | November 09, 18 | 0.3 | 0.3 | 2018-11-12 | 2018-11-29 | 2018-10-30 |
| 2018-08-02 | August 02, 18 | 0.6 | 0.6 | 2018-08-03 | 2018-09-07 | 2018-05-17 |
| 2018-02-15 | February 15, 18 | 0.3 | 0.3 | 2018-02-19 | 2018-03-09 | 2018-02-06 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.00 Cr | 0.05 Cr | -0.05 Cr | 0.0000 | 0.00 Cr | 0.00 Cr | -7.52 Cr | 37.47 Cr | 2.56 | 2.74 Cr | 0.0000 |
| 2024-03-31 | 65.61 Cr | 24.44 Cr | 41.17 Cr | 0.6275 | 0.00 Cr | 7.87 Cr | -5.61 Cr | -119.62 Cr | -8.18 | -105.08 Cr | -1.8233 |
| 2023-03-31 | 189.07 Cr | 83.01 Cr | 106.06 Cr | 0.5610 | 0.01 Cr | 9.98 Cr | 5.82 Cr | -100.27 Cr | -6.86 | -20.98 Cr | -0.5303 |
| 2022-03-31 | 652.65 Cr | 192.85 Cr | 459.79 Cr | 0.7045 | 7.07 Cr | 76.93 Cr | -60.11 Cr | -782.25 Cr | -53.50 | 26.90 Cr | -1.1986 |
| 2021-03-31 | 774.02 Cr | 188.08 Cr | 585.94 Cr | 0.7570 | 0.00 Cr | 69.84 Cr | -149.89 Cr | -452.02 Cr | -30.91 | -286.13 Cr | -0.5840 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.37 Cr | 36.48 Cr | 15.95 Cr | 20.5270 Cr | 0.00 Cr | -3.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 15.9540 Cr |
| 2024-03-31 | 0.85 Cr | 88.11 Cr | 96.98 Cr | -8.8730 Cr | 37.09 Cr | 36.24 Cr | 0.80 Cr | 28.50 Cr | 18.61 Cr | 0.00 Cr | 3.13 Cr | 89.1570 Cr |
| 2023-03-31 | 10.72 Cr | 224.38 Cr | 115.78 Cr | 108.6020 Cr | 46.37 Cr | 35.65 Cr | 0.78 Cr | 54.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 100.9010 Cr |
| 2022-03-31 | 29.00 Cr | 1,223.10 Cr | 1,042.47 Cr | 181.0430 Cr | 77.99 Cr | 48.99 Cr | 0.65 Cr | 48.17 Cr | 33.46 Cr | 0.00 Cr | -5.96 Cr | 1,006.7520 Cr |
| 2021-03-31 | 32.42 Cr | 1,844.59 Cr | 720.29 Cr | 1,124.6920 Cr | 549.67 Cr | 517.25 Cr | 0.61 Cr | 229.98 Cr | 49.20 Cr | 0.00 Cr | 7.44 Cr | 524.2980 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -16.1800 Cr | 22.0200 Cr | -3.2390 Cr | -16.3660 Cr | 2.4870 Cr | 3.3670 Cr | 0.0000 Cr | 37.4400 Cr | -3.2000 Cr | -0.0390 Cr | 0.0000 Cr |
| 2024-03-31 | 9.3160 Cr | -7.4620 Cr | -11.7350 Cr | 1.4000 Cr | -9.8780 Cr | 0.8450 Cr | -7.9160 Cr | -119.6200 Cr | -5.3000 Cr | -0.0730 Cr | -0.0200 Cr |
| 2023-03-31 | 20.0150 Cr | -2.1252 Cr | -35.7210 Cr | -12.3810 Cr | -18.2740 Cr | 10.7236 Cr | -32.3960 Cr | -98.6740 Cr | -25.2520 Cr | -0.0680 Cr | -0.1270 Cr |
| 2022-03-31 | 120.3110 Cr | -30.6410 Cr | -54.5170 Cr | 89.0990 Cr | -9.9770 Cr | 28.9970 Cr | -31.2120 Cr | -771.0180 Cr | -8.0880 Cr | -0.0070 Cr | 0.0000 Cr |
| 2021-03-31 | 135.2390 Cr | -56.9890 Cr | -83.9460 Cr | 132.0840 Cr | -6.1580 Cr | 38.9740 Cr | -3.1480 Cr | -435.6200 Cr | -40.6790 Cr | 0.0000 Cr | 0.0000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | -0.78 Cr | -0.91 Cr | -0.06 | -0.73 Cr | 0.0000 |
| 2025-03-31 | 0.00 Cr | 0.01 Cr | -0.01 Cr | 0.0000 | -1.15 Cr | -4.88 Cr | -0.33 | 0.56 Cr | 0.0000 |
| 2024-12-31 | 8.52 Cr | 0.00 Cr | -0.01 Cr | -0.0013 | -1.89 Cr | 47.68 Cr | 3.26 | 5.63 Cr | 5.5939 |
| 2024-09-30 | 0.00 Cr | 0.01 Cr | -0.01 Cr | 0.0000 | -1.23 Cr | -1.58 Cr | -0.11 | -1.22 Cr | 0.0000 |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | 0.00 Cr | -3.75 Cr | -0.26 | -2.23 Cr | 0.0000 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.37 Cr | 12.32 Cr | 15.69 Cr | 0.00 Cr | 0.00 Cr | 23.55 Cr | 0.00 Cr | 36.48 Cr | 15.95 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.61 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 14.17 Cr |
| 2024-09-30 | 0.51 Cr | 0.68 Cr | 1.19 Cr | 0.29 Cr | 0.00 Cr | 72.55 Cr | 0.07 Cr | 86.70 Cr | 100.87 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 8.87 Cr |
| 2024-03-31 | 0.85 Cr | 0.00 Cr | 0.85 Cr | 21.84 Cr | 0.80 Cr | 35.28 Cr | 28.50 Cr | 88.11 Cr | 96.98 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 47.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -1.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -3.75 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -110.61 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -2.14 Cr | 3.71 Cr | 0.00 Cr | 0.00 Cr | 3.71 Cr | 4.85 Cr | 1.14 Cr | 0.00 Cr | 3.71 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2008-09-18 | September 18, 08 | 10:1 |
Similar Stocks: Biotechnology
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Biocon Limited | BIOCON | ₹360.25 | ₹481,639,840,000.00 | ₹2,377,375.00 |
| Syngene International Limited | SYNGENE | ₹659.15 | ₹264,559,669,880.00 | ₹531,474.00 |
| Piramal Pharma Limited | PPLPHARMA | ₹192.13 | ₹255,388,456,666.00 | ₹2,518,788.00 |
| Concord Biotech Limited | CONCORDBIO | ₹1,633.60 | ₹170,901,024,320.00 | ₹64,779.00 |
| Blue Jet Healthcare Limited | BLUEJET | ₹791.75 | ₹137,341,246,285.00 | ₹618,017.00 |
| Jubilant Ingrevia Limited | JUBLINGREA | ₹698.20 | ₹111,209,994,200.00 | ₹170,522.00 |
| Supriya Lifescience Limited | SUPRIYA | ₹656.00 | ₹52,796,716,800.00 | ₹99,003.00 |
| Dishman Carbogen Amcis Limited | DCAL | ₹254.90 | ₹39,963,986,700.00 | ₹44,875.00 |
| Zota Health Care Limited | ZOTA | ₹1,339.30 | ₹39,460,465,550.00 | ₹193,378.00 |
| Panacea Biotec Limited | PANACEABIO | ₹430.65 | ₹26,377,613,955.00 | ₹150,143.00 |
Key Executives
Gender: male
Year Born:
Gender: Not Specified
Year Born:
Gender: male
Year Born: 1964
Gender: female
Year Born: 1970
FAQs about TAKE Solutions Limited
The CEO is Shobana Nadathur Srinivasan.
The current price is ₹9.00.
The range is ₹6.51-23.69.
The market capitalization is ₹133.14 crores.
The P/E ratio is 3.39.
The company operates in the Healthcare sector.
Overview of TAKE Solutions Limited (ISIN: INE142I01023) is a leading Biotechnology in India. With a market capitalization of ₹133.14 crores and an average daily volume of 39,177 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.